Home » Regulators Clear Lotus Pharmaceuticals Asthma Drug for Clinical Trials
Regulators Clear Lotus Pharmaceuticals Asthma Drug for Clinical Trials
Lotus Pharmaceuticals, Inc., a Chinese developer, manufacturer and seller of medicine and drugs, said that its asthma drug Laevo-Bambuterol has received
approval from China’s State Food & Drug Administration to begin clinical trials.
Benzinga
Benzinga
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May